$SAVA Surges Over 20% to $36, Up Over $10 Amid Market Sell-Off

$SAVA, a biotech stock, has seen significant upward movement recently, rising over $10 in value. On August 5, 2024, the stock reached $36, marking a notable increase of approximately 20% on that day alone. This surge comes amid a broader market sell-off, suggesting strong short covering activity. Investors have expressed mixed sentiments about the stock's volatility, with some noting it has become a challenging environment for short sellers. The stock's performance has drawn attention, with analysts highlighting its deviation from general market trends.